Home Investing Novo Nordisk shares pop as drugmaker sees copycat Wegovy sales easing in 2025

Novo Nordisk shares pop as drugmaker sees copycat Wegovy sales easing in 2025

by admin

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

You may also like

Leave a Comment

two × 5 =